Skip to content

Clinical trials

Peripheral Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Nervous System Diseases Clear all

475 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20025
200315
20043
200512
200612
20079
20084
200914
20109
201115
201214
20138
201417
201524
201622
201718
201822
201926
202019
202120
202230
202336
202426
202532
202644

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed244
Unknown status75
Recruiting55
Terminated33
Not yet recruiting32
Active, not recruiting21
Withdrawn13
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NeurogesX11
Mayo Clinic7
National Institute of Allergy and Infectious Diseases (NIAID)7
Assiut University6
National Taiwan University Hospital6
Washington University School of Medicine6
Ain Shams University5
Istanbul University5
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.5
M.D. Anderson Cancer Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Nervous System Diseases475
Pain68
Diabetes Mellitus50
Breast Neoplasms48
Neuralgia44
Diabetic Neuropathies33
HIV Infections21
Chronic Pain18
Polyneuropathies18
Neoplasms17

Trials

Showing 26 to 50 of 475. Each trial links to its page on Pharma Observatory.

375 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.